Immuneering Corp - Class A

NAS:IMRX (USA)   Class A
$ 6.46 +0.04 (+0.62%) 10:08 PM EST
At Loss
P/B:
1.82
Market Cap:
$ 189.08M
Enterprise V:
$ 96.38M
Volume:
52.07K
Avg Vol (2M):
49.93K
Volume:
52.07K
At Loss
Avg Vol (2M):
49.93K

Business Description

Immuneering Corp
NAICS : 325412 SIC : 2834
ISIN : US45254E1073

Share Class Description:

IMRX: Class A
Description
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to leading pharmaceutical and biotechnology companies.
Name Current Vs Industry Vs History
Cash-To-Debt 21.41
Equity-to-Asset 0.91
Debt-to-Equity 0.04
Debt-to-EBITDA -0.08
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 48.36
9-Day RSI 51.86
14-Day RSI 51.29
6-1 Month Momentum % -41.4
12-1 Month Momentum % 11.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.89
Quick Ratio 17.89
Cash Ratio 17.3

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -45.5
Shareholder Yield % 0.18

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -15515.14
ROE % -47.06
ROA % -42.85
ROIC % -404.64
ROC (Joel Greenblatt) % -992.38
ROCE % -49.16

Financials (Next Earnings Date:2024-03-06 Est.)

IMRX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IMRX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Immuneering Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.317
EPS (TTM) ($) -1.87
Beta 0
Volatility % 116.56
14-Day RSI 51.29
14-Day ATR ($) 0.447127
20-Day SMA ($) 6.27625
12-1 Month Momentum % 11.2
52-Week Range ($) 4.51 - 14.29
Shares Outstanding (Mil) 29.27

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Immuneering Corp Filings

Filing Date Document Date Form
No Filing Data

Immuneering Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Immuneering Corp Frequently Asked Questions

What is Immuneering Corp(IMRX)'s stock price today?
The current price of IMRX is $6.46. The 52 week high of IMRX is $14.29 and 52 week low is $4.51.
When is next earnings date of Immuneering Corp(IMRX)?
The next earnings date of Immuneering Corp(IMRX) is 2024-03-06 Est..
Does Immuneering Corp(IMRX) pay dividends? If so, how much?
Immuneering Corp(IMRX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1